SALVAGENIX
Live / Allowed — Published for opposition (as of 10 Feb 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 29 Aug 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99365580
- Mark type
- Stylized text
- Filed
- 29 Aug 2025
- Published for opposition
- 10 Feb 2026
- Attorney of record
- Sherry L. Rollo
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of digoxin, digitalis or other cardio-active glycoside toxicity; Veterinary preparations for digoxin, digitalis or other cardio-active glycoside toxicity; Pharmaceutical preparations for the treatment of pre-eclampsia;; Chemical reagents for medical or veterinary use; Pharmaceutical preparations for use in the treatment of digoxin, digitalis or other cardio-active glycoside toxicity, and for use in the treatment of pre-eclampsia;; Chemical preparations for pharmaceutical or medical purposes, namely, for medicines for use in the treatment of digoxin, digitalis or other cardio-active glycoside toxicity and for use in the treatment of pre-eclampsia; Veterinary preparations for the treatment of pre-eclampsia;
Owner
- Salvagenix Inc., Wilmington, DE, US
- Salvagenix Inc., Wilmington, DE, US
Prosecution history
- 10 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Feb 2026 — PUBLISHED FOR OPPOSITION
- 04 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 14 Jan 2026 — ASSIGNED TO EXAMINER
- 29 Aug 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 29 Aug 2025 — APPLICATION FILING RECEIPT MAILED
- 29 Aug 2025 — NEW APPLICATION ENTERED